
Stanford University Ventures
475 Via Ortega, Suite 004, Stanford, CA, 94305, United States
Overview
STVP accelerates entrepreneurship education at Stanford and around the world. As the entrepreneurship center in Stanford’s School of Engineering, the Stanford Technology Ventures Program delivers courses and extracurricular programs to Stanford students, creates scholarly research on high-impact technology ventures, and produces a large and growing collection of online content and experiences for people around the world. STVP is dedicated to accelerating high-technology entrepreneurship education and creating scholarly research on technology-based firms that, in turn, provides new insights for students, scholars, and business leaders. Located in the heart of Silicon Valley, the Stanford Technology Ventures Program (STVP) is the entrepreneurship center at Stanford University's School of Engineering. Hosted by the Department of Management Science and Engineering, STVP is dedicated to accelerating high-technology entrepreneurship education and creating scholarly research on technology-based firms that, in turn, provides new insights for students, scholars and business leaders. STVP provides undergraduate and graduate students from all majors with the entrepreneurial skills needed to use innovations to solve major world problems, with an emphasis on the environment, human health, information technology and other global issues. STVP research efforts tackle the challenges of creating successful ventures and innovative large firms, and then taking that knowledge to the classroom and publication. STVP global-outreach program includes partnerships with faculty abroad seeking to enhance entrepreneurship education in their own countries, as well as a website that includes thousands of video clips and podcasts regarding technology entrepreneurship and innovation. STVP strives to create new ideas, and inspire and prepare students to be leaders in existing organizations, new ventures and academia.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 5
Sector focus
- Education
- Non Profit
- Social Entrepreneurship
Investment portfolio
- Stellaromics
Participated · Series B · Feb 2025
Stellaromics develops Pyxa, a 3D spatial biology platform that visualizes and analyzes the spatial organization of cells and molecules in thick tissue samples at sub-cellular resolution. The technology builds on the company’s STARmap and RIBOmap methods to enable multi-omic spatial profiling across hundreds to thousands of genes. Pyxa supports analysis of tissue slices 100μm thick or more and offers automated workflows and advanced 3D visualization software. The company says initial users in neuroscience, oncology, and immunology are already leveraging the platform. An early access program is fully subscribed and initial commercial shipments are estimated to begin at the end of 2025, with broader launch activities planned at conferences such as AGBT 2025. Stellaromics is headquartered in Boston and was spun out of the laboratories of Karl Deisseroth and Xiao Wang. Stellaromics is a Boston, MA-based company developing in situ spatial multi-omics technology to map gene expression within intact tissue. Its flagship product, STARmap (Spatially-resolved Transcript Amplicon Readout mapping), reveals gene expression patterns within intact tissue to aid target identification and biomedical research. The company is in late-stage product development on its Plexa™ suite, with an alpha version expected to be available via a Technology Access Program in early 2024. Stellaromics intends to use the funds from the Series A to consolidate the business and establish a new headquarters to house its growing team. Founded in 2022 by Karl Deisseroth, M.D., Ph.D., and Xiao Wang, Ph.D., the company aims to accelerate development of novel drug treatments across autoimmune diseases, cancer, neuropsychiatric disorders, and infectious diseases. In tandem with the fundraise, Stellaromics appointed Todd Dickinson, Ph.D., as President & CEO and Ye Fu, Ph.D., as CTO.